These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21405968)

  • 1. Integrating biomarkers in clinical trials.
    Buyse M; Michiels S; Sargent DJ; Grothey A; Matheson A; de Gramont A
    Expert Rev Mol Diagn; 2011 Mar; 11(2):171-82. PubMed ID: 21405968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parallel paths to predictive biomarkers in oncology: Uncoupling of emergent biomarker development and phase III trial execution.
    Sikorski R; Yao B
    Sci Transl Med; 2009 Dec; 1(10):10ps11. PubMed ID: 20368158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trials.
    Shi Q; Mandrekar SJ; Sargent DJ
    Scand J Gastroenterol; 2012 Mar; 47(3):356-62. PubMed ID: 22181041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial designs for predictive marker validation in cancer treatment trials.
    Sargent DJ; Conley BA; Allegra C; Collette L
    J Clin Oncol; 2005 Mar; 23(9):2020-7. PubMed ID: 15774793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficiency of clinical trial designs for predictive biomarker validation.
    Young KY; Laird A; Zhou XH
    Clin Trials; 2010 Oct; 7(5):557-66. PubMed ID: 20571132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The designs of exploratory biomarker study].
    Gosho M; Nagashima K; Sato Y
    Nihon Rinsho; 2012 May; 70(5):874-9. PubMed ID: 22620016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncology biomarkers: discovery, validation, and clinical use.
    Heckman-Stoddard BM
    Semin Oncol Nurs; 2012 May; 28(2):93-8. PubMed ID: 22542316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing the future shape of breast cancer diagnosis, prognosis and treatment.
    Dowsett M
    Breast Cancer Res Treat; 2004; 87 Suppl 1():S27-9. PubMed ID: 15597218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials.
    Pizer BL; Clifford SC
    Br J Neurosurg; 2009 Aug; 23(4):364-75. PubMed ID: 19637007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers and surrogates in clinical studies.
    Rigatto C; Barrett BJ
    Methods Mol Biol; 2009; 473():137-54. PubMed ID: 19160736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk factors for selecting cohorts for large-scale chemoprevention trials.
    Greenwald P
    J Cell Biochem Suppl; 1996; 25():29-36. PubMed ID: 9027595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel designs and end points for phase II clinical trials.
    Adjei AA; Christian M; Ivy P
    Clin Cancer Res; 2009 Mar; 15(6):1866-72. PubMed ID: 19276272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers in aquatic plants: selection and utility.
    Brain RA; Cedergreen N
    Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualizing the landscape of selection biomarkers in current phase III oncology clinical trials.
    Sikorski R; Yao B
    Sci Transl Med; 2010 Jun; 2(34):34ps27. PubMed ID: 20519717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological markers in lung cancer: A clinician's perspective.
    Tufman A; Huber RM
    Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological biomarkers in psoriatic disease. A review.
    de Vlam K; Gottlieb AB; Fitzgerald O
    J Rheumatol; 2008 Jul; 35(7):1443-8. PubMed ID: 18609742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A standardization method to adjust for the effect of patient selection in phase II clinical trials.
    Mazumdar M; Fazzari M; Panageas KS
    Stat Med; 2001 Mar; 20(6):883-92. PubMed ID: 11252010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of sepsis.
    Marshall JC; Reinhart K;
    Crit Care Med; 2009 Jul; 37(7):2290-8. PubMed ID: 19487943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents.
    Le Tourneau C; Vidal L; Siu LL
    Drug Resist Updat; 2008 Jun; 11(3):99-109. PubMed ID: 18515176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.